Mylan Pharmaceuticals, the U.S.-based business of Mylan N.V., recalled certain lots of ulcer medication Nizatidine in the form of capsules for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA). Trace amounts of the impurity was found in the Active Pharmaceutical Ingredient (API) manufactured by India-based Solara Active Pharma Sciences Ltd.
from RTT - Biotech https://ift.tt/304nmJv
via IFTTT
No comments:
Post a Comment